[Retracted] Risedronate Effects on the In Vivo Bioactive Glass Behavior: Nuclear Magnetic Resonance and Histopathological Studies

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_center" colspan="3"><svg height="11.8174pt" id="M18" style="vertical-align:-3.1815pt" version="1.1" viewbox="-0.0498162 -8.6359 12.6378 11.8174" width="12.6378pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M645 631C614 643 545 666 457 666C215 666 23 519 23 283C23 90 158 -16 337 -16C412 -16 489 2 522 10C543 39 590 127 606 167L580 181C519 89 459 18 348 18C201 18 122 136 122 287C122 464 244 632 435 632C544 632 602 595 608 472L639 475C643 526 645 581 645 631Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,8.619,3.132)"><path d="M181 342V451C133 431 89 419 40 411V388C98 381 102 377 102 311V104C102 38 95 32 33 26V0H263V26C186 32 181 38 181 104V287C203 343 235 372 261 372C277 372 289 366 304 352C310 346 318 345 330 350C349 359 362 379 362 399C362 422 338 449 304 449C256 449 213 393 183 342H181Z"></path></g></svg> (Mm)</td></tr><tr class="thead"><td class="align_left">Composites</td><td class="align_center">1 day</td><td class="align_center">15 days</td><td class="align_center">30 days</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">46S6-8RIS</td><td class="align_center">0.29</td><td class="align_center">0.19</td><td class="align_center">0.19</td></tr><tr><td class="align_left">46S6-12RIS</td><td class="align_center">0.49</td><td class="align_center">0.08</td><td class="align_center">0.05</td></tr><tr><td class="align_left">46S6-20RIS</td><td class="align_center">0.79</td><td class="align_center">0.47</td><td class="align_center">0.39</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Concentrations of risedronate retained on the 46S6 surface (<span class="nowrap"><svg height="11.8174pt" id="M17" style="vertical-align:-3.1815pt" version="1.1" viewbox="-0.0498162 -8.6359 12.6378 11.8174" width="12.6378pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M645 631C614 643 545 666 457 666C215 666 23 519 23 283C23 90 158 -16 337 -16C412 -16 489 2 522 10C543 39 590 127 606 167L580 181C519 89 459 18 348 18C201 18 122 136 122 287C122 464 244 632 435 632C544 632 602 595 608 472L639 475C643 526 645 581 645 631Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,8.619,3.132)"><path d="M181 342V451C133 431 89 419 40 411V388C98 381 102 377 102 311V104C102 38 95 32 33 26V0H263V26C186 32 181 38 181 104V287C203 343 235 372 261 372C277 372 289 366 304 352C310 346 318 345 330 350C349 359 362 379 362 399C362 422 338 449 304 449C256 449 213 393 183 342H181Z"></path></g></svg>)</span> after its immersion in the SBF solution.</div>

BioMed Research International

tab3

Table 3

Table 3: [Retracted] Risedronate Effects on the In Vivo Bioactive Glass Behavior: Nuclear Magnetic Resonance and Histopathological Studies 